OrbiMed and NovaQuest close healthcare funds worth $1.2bn
This article was originally published in Scrip
Two private investment firms have announced that they have closed funds focused on the healthcare sector which between them have almost $1.2bn to invest.
You may also be interested in...
BioNTech extends Pfizer partnership to cover COVID-19 vaccine development and distribution while Fosun Pharma takes Chinese rights.
Dietmar Hopp, 80% shareholder of German mRNA company CureVac, has rejected the possibility that the company would sign an exclusive deal with the US for its investigational coronavirus vaccine.
Infographic: Scrip homes in on key figures for companies integrating major acquisitions or divesting significant parts of their business.